MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Supernus Pharmaceuticals, Inc.

SUPN

#1402
Supernus Pharmaceuticals, Inc.
54.7300
+0.48%
Sector:
Base:
Profit Currency:
Daily Range
54.7300
54.7300
Year Range
43.1100
59.6800
Daily Change
+0.48%
Monthly Change
+10.77%
6 month change
+1.35%
Year Change
+1.35%
Previous Close
54.4700
Open
54.7300
Bid
Ask
Low
54.7300
High
54.7300
Volume
97
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. SUPN
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
SUPN
2026.02.25
TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch
Investing Investing
SUPN
2026.02.25
Supernus Pharmaceuticals stock hits 52-week high at $57.76
Investing Investing
SUPN
2026.02.25
Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains
Zacks Zacks
SUPN ASMB
2026.02.25
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
Investing Investing
SUPN
2026.02.24
Supernus earnings missed by $0.48, revenue topped estimates
Investing Investing
SUPN
2026.02.24
Supernus faces earnings test after Q3 shock to profitability
Zacks Zacks
SUPN BBIO
2026.02.17
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline
Zacks Zacks
BIIB SUPN
2026.02.06
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
Zacks Zacks
BIIB MRNA JAZZ SUPN
2026.02.03
New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings
Seeking Alpha Seeking Alpha
SUPN
2026.02.01
Supernus - Outlook For 2026 Positive, Upholding Buy Rating (NASDAQ:SUPN)
Investing Investing
SUPN
2026.01.28
Supernus Pharmaceuticals amends merger agreement to adjust milestone payments
Investing Investing
SUPN
2026.01.09
Cantor Fitzgerald reiterates Overweight rating on Supernus Pharmaceuticals stock

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd